Help us: Donate
Follow us on:



Tag: Investment

April 01, 2021
VitaDAO wants to democratize biotech VitaDAO will aim to fund longevity research, give its members ownership of the resulting IP, and allow members to vote on the direction of the organization. Few would argue that the drug development process is efficient. Even as the technology surrounding the process gets better and cheaper, the time and...
Maximon logo
March 08, 2021
We kick off the week with some news from Switzerland and introduce the new longevity biotech company builder Maximon. The enthusiasm for technologies to promote longevity and even increase healthy human lifespan seems to be rising in Switzerland. There are frequently articles in the popular press about the topic and we were even asked to...
Bold logo
February 26, 2021
Thanks to an injection of seed round cash, a new company, Bold, joins the growing pool of organizations that are focused on wellness and disease prevention. The rising interest in wellness and healthy aging It’s no secret that the interest in digital health and wellness has risen in recent years along with the popularity of...
Interview image for Tina Woods
January 05, 2021
Tina Woods is a UK-based founder of several social enterprises in healthcare and longevity and the author of the book Live Longer with AI, which we recently reviewed. In this interview, Tina shares valuable insights on how social entrepreneurship works in our field, what governments can and must do to promote healthy aging, and what...
Dr. Alexandra Bause at Ending Age-Related Diseases 2020
December 24, 2020
In this presentation given at Ending Age-Related Diseases 2020, Dr. Alexandra Bause of Apollo Venture discusses biotech investment in an aging world, explaining current demographic trends, the multimorbidities associated with an aging population, and the need of healthspan-enhancing biotechnology to meet this need. She brings up the hallmarks of aging and suggests multiple methods of...
Dr. Tyler Golato
December 15, 2020
In this presentation given at Ending Age-Related Diseases 2020, Dr. Tyler Golato talked about his company, Molecule, highlighting the current problems with pharmaceutical development and offering a new, decentralized method of developing therapies. He discussed the well-known valley of death, the gap between the basic research of academia and the later-stage development of pharmaceutical companies....